LYMPHATIC MALFORMATIONS
Clinical trials for LYMPHATIC MALFORMATIONS explained in plain language.
Never miss a new study
Get alerted when new LYMPHATIC MALFORMATIONS trials appear
Sign up with your email to follow new studies for LYMPHATIC MALFORMATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets rare growths in kids and adults
Disease control Recruiting nowThis study tests whether alpelisib can shrink lymphatic malformations (abnormal fluid-filled growths) in people with a specific PIK3CA gene mutation. About 232 children and adults will receive either alpelisib or a placebo. The main goal is to see if the growths shrink by at leas…
Matched conditions: LYMPHATIC MALFORMATIONS
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:38 UTC
-
New drug aims to shrink overgrown tissue in rare genetic disorder
Disease control Recruiting nowThis study tests a new drug, RLY-2608, in adults and children with rare conditions that cause abnormal overgrowth of body parts (like limbs or organs) due to a PIK3CA gene mutation. The drug targets only the mutated protein to try to reduce the size of overgrown tissue and improv…
Matched conditions: LYMPHATIC MALFORMATIONS
Phase: PHASE2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:34 UTC